Milano (1)

Well Differentiated Pancreatic Endocrine Tumor (1)

Active, not recruiting (1)

phase 2 (1)

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano (1)

everolimus plus octreotide lar plus metformin (1)

drug (1)

Other (1)

Interventional (1)

well differentiated pancreatic endocrine tumor

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Sep 3, 2021